OpenURL Connection Search

Select item for more details and to access through your institution.

Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target.
Published in:
Journal of Personalized Medicine, 2021, v. 11, n. 7, p. 619, doi. 10.3390/jpm11070619
By:
- Motomura, Takashi;
- Amirneni, Sriram;
- Diaz-Aragon, Ricardo;
- Faccioli, Lanuza A. P.;
- Malizio, Michelle R.;
- Coard, Michael C.;
- Kocas-Kilicarslan, Zehra N.;
- Frau, Carla;
- Haep, Nils;
- Ostrowska, Alina;
- Florentino, Rodrigo M.;
- Soto-Gutierrez, Alejandro
Publication type:
Article
Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapy.
Published in:
Frontiers in Cell & Developmental Biology, 2024, p. 1, doi. 10.3389/fcell.2024.1423936
By:
- Mengying Xia;
- Varmazyad, Mahboubeh;
- Pla-Palacín, Iris;
- Gavlock, Dillon C.;
- DeBiasio, Richard;
- LaRocca, Gregory;
- Reese, Celeste;
- Florentino, Rodrigo M.;
- Faccioli, Lanuza A. P.;
- Brown, Jacquelyn A.;
- Vernetti, Lawrence A.;
- Schurdak, Mark;
- Stern, Andrew M.;
- Gough, Albert;
- Behari, Jaideep;
- Soto-Gutierrez, Alejandro;
- Taylor, D. Lansing;
- Miedel, Mark T.
Publication type:
Article
Safety and Biodistribution of an Autologous Bone Marrow‐Derived Mononuclear Cell Infusion into Renal Arteries in Patients with Focal Segmental Glomerulosclerosis: A Phase 1 Study.
Published in:
Stem Cells International, 2024, v. 2024, p. 1, doi. 10.1155/2024/2385568
By:
- Botelho, Bruno Freire;
- Barreira, André Luis;
- Filippo, Marcio Gomes;
- Asensi, Karina Dutra;
- Faccioli, Lanuza A P;
- dos Santos Salgado, Anna Beatriz;
- de Salles, Elizabeth Figueiredo;
- Marques, Carlos Eduardo Cruz;
- Silva, Pedro Leme;
- dos Santos Goldenberg, Regina Coeli;
- Maiolino, Angelo;
- Gutfilen, Bianca;
- de Souza, Sergio Augusto Lopes;
- Junior, Maurilo Leite;
- Morales, Marcelo Marcos;
- Rahman, Md Shaifur
Publication type:
Article
Evaluation of Human Hepatocyte Drug Metabolism Carrying High-Risk or Protection-Associated Liver Disease Genetic Variants.
Published in:
International Journal of Molecular Sciences, 2023, v. 24, n. 17, p. 13406, doi. 10.3390/ijms241713406
By:
- Faccioli, Lanuza A. P.;
- Cetin, Zeliha;
- Kocas-Kilicarslan, Zehra N.;
- Ortiz, Kimberly;
- Sun, Yiyue;
- Hu, Zhiping;
- Kurihara, Takeshi;
- Tafaleng, Edgar N.;
- Florentino, Rodrigo M.;
- Wang, Zi;
- Xia, Mengying;
- Miedel, Mark T.;
- Taylor, D. Lansing;
- Behari, Jaideep;
- Ostrowska, Alina;
- Constantine, Robert;
- Li, Albert;
- Soto-Gutierrez, Alejandro
Publication type:
Article

Found: 4

Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target.

Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapy.

Safety and Biodistribution of an Autologous Bone Marrow‐Derived Mononuclear Cell Infusion into Renal Arteries in Patients with Focal Segmental Glomerulosclerosis: A Phase 1 Study.

Evaluation of Human Hepatocyte Drug Metabolism Carrying High-Risk or Protection-Associated Liver Disease Genetic Variants.